246 related articles for article (PubMed ID: 25682933)
1. Stereotactic body radiotherapy for liver metastases.
Aitken KL; Hawkins MA
Clin Oncol (R Coll Radiol); 2015 May; 27(5):307-15. PubMed ID: 25682933
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiotherapy for oligometastatic disease.
Hanna GG; Landau D
Clin Oncol (R Coll Radiol); 2015 May; 27(5):290-7. PubMed ID: 25770653
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic ablative body radiotherapy for lung cancer.
Franks KN; Jain P; Snee MP
Clin Oncol (R Coll Radiol); 2015 May; 27(5):280-9. PubMed ID: 25746732
[TBL] [Abstract][Full Text] [Related]
4. [Stereotactic body radiation therapy (SBRT) in the treatment of liver metastases: state of the art].
De Bari B; Guillet M; Mornex F
Cancer Radiother; 2011 Feb; 15(1):72-6. PubMed ID: 21216647
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiation therapy for liver metastases.
Dawood O; Mahadevan A; Goodman KA
Eur J Cancer; 2009 Nov; 45(17):2947-59. PubMed ID: 19773153
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of individualized stereotactic body radiotherapy of liver metastases.
Lee MT; Kim JJ; Dinniwell R; Brierley J; Lockwood G; Wong R; Cummings B; Ringash J; Tse RV; Knox JJ; Dawson LA
J Clin Oncol; 2009 Apr; 27(10):1585-91. PubMed ID: 19255313
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease.
Ahmed KA; Torres-Roca JF
Cancer Control; 2016 Jan; 23(1):21-9. PubMed ID: 27009453
[TBL] [Abstract][Full Text] [Related]
8. A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial).
Mercier C; Dirix P; Meijnders P; Vermeulen P; Van Laere S; Debois H; Huget P; Verellen D
Radiat Oncol; 2018 Aug; 13(1):152. PubMed ID: 30126440
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer.
Iyengar P; Westover K; Timmerman RD
Semin Respir Crit Care Med; 2013 Dec; 34(6):845-54. PubMed ID: 24258574
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials of stereotactic ablative radiotherapy for prostate cancer: updates and future direction.
Musunuru HB; Loblaw A
Future Oncol; 2015; 11(5):819-31. PubMed ID: 25757684
[TBL] [Abstract][Full Text] [Related]
11. Radiation therapy for liver metastases.
Schefter TE; Kavanagh BD
Semin Radiat Oncol; 2011 Oct; 21(4):264-70. PubMed ID: 21939855
[TBL] [Abstract][Full Text] [Related]
12. Low Hepatic Toxicity in Primary and Metastatic Liver Cancers after Stereotactic Ablative Radiotherapy Using 3 Fractions.
Bae SH; Kim MS; Jang WI; Cho CK; Yoo HJ; Kim KB; Han CJ; Park SC; Lee DH
J Korean Med Sci; 2015 Aug; 30(8):1055-61. PubMed ID: 26240482
[TBL] [Abstract][Full Text] [Related]
13. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiation therapy. Rationale, techniques, applications, and optimization.
Song DY; Kavanagh BD; Benedict SH; Schefter T
Oncology (Williston Park); 2004 Oct; 18(11):1419-30; discussion 1430, 1432, 1435-6. PubMed ID: 15609470
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.
Méndez Romero A; Wunderink W; Hussain SM; De Pooter JA; Heijmen BJ; Nowak PC; Nuyttens JJ; Brandwijk RP; Verhoef C; Ijzermans JN; Levendag PC
Acta Oncol; 2006; 45(7):831-7. PubMed ID: 16982547
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic ablative radiotherapy for oligometastatic disease in liver.
Kim M; Son SH; Won YK; Kay CS
Biomed Res Int; 2014; 2014():340478. PubMed ID: 24868526
[TBL] [Abstract][Full Text] [Related]
17. The evolving role of radiotherapy in treatment of oligometastatic NSCLC.
Bergsma DP; Salama JK; Singh DP; Chmura SJ; Milano MT
Expert Rev Anticancer Ther; 2015; 15(12):1459-71. PubMed ID: 26536370
[TBL] [Abstract][Full Text] [Related]
18. Image-guided stereotactic ablative radiotherapy for the liver: a safe and effective treatment.
Van De Voorde L; Vanneste B; Houben R; Damen P; van den Bogaard J; Lammering G; Dejong K; de Vos-Geelen J; Buijsen J; Öllers M; Berbée M; Lambin P
Eur J Surg Oncol; 2015 Feb; 41(2):249-56. PubMed ID: 25468743
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiation therapy for liver metastasis--case report and review of the literature. The role of patient preparation, treatment planning and its delivery.
Adamczyk M; Fundowicz M
J Cancer Res Ther; 2014; 10(3):519-25. PubMed ID: 25313731
[TBL] [Abstract][Full Text] [Related]
20. Disease volume and distribution as drivers of treatment decisions in metastatic prostate cancer: From chemohormonal therapy to stereotactic ablative radiotherapy of oligometastases.
Saluja R; Cheung P; Zukotynski K; Emmenegger U
Urol Oncol; 2016 May; 34(5):225-32. PubMed ID: 27008982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
